Does increased local bone resorption secondary to breast and prostate cancer result in increased cartilage degradation?

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Leeming, Diana J ^a   Byrjalsen, Inger ^a   Qvist, Per ^a   Koizumi, Mitsuru ^b   Lynnerup, Niels ^c   Fregerslev, Michael ^c   Sørensen, Mette G ^a   Christiansen, Claus ^a   Karsdal, Morten A ^a  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; COLLAGEN TYPE 1; COLLAGEN TYPE 2; CATHEPSIN; CTSK PROTEIN, HUMAN;

ARTICLE; BONE METASTASIS; BONE TURNOVER; BREAST CANCER; CANCER GRADING; CANCER PATIENT; CARTILAGE DEGENERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; OSTEOCLAST; OSTEOLYSIS; PROSTATE CANCER; PROTEIN SECRETION; SCORING SYSTEM; BONE; BONE TUMOR; BREAST TUMOR; CARTILAGE; FEMALE; LUNG TUMOR; METABOLISM; METASTASIS; PATHOLOGY; PROSTATE TUMOR; URINE;

BONE AND BONES; BONE NEOPLASMS; BONE RESORPTION; BREAST NEOPLASMS; CARTILAGE; CATHEPSIN K; CATHEPSINS; COLLAGEN TYPE I; COLLAGEN TYPE II; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; OSTEOCLASTS; PROSTATIC NEOPLASMS;

EID: 47749090968     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-180     Document Type: Article

References (22)

1. Yin JJ Pollock CB Kelly K Mechanisms of cancer metastasis to the bone Cell Res 2005, 15:57-62. 10.1038/sj.cr.7290266 15686629
2. Roodman GD Mechanisms of bone metastasis N Engl J Med 2004, 350:1655-1664. 10.1056/NEJMra030831 15084698
3. Bonde M Qvist P Fledelius C Riis BJ Christiansen C Immunoassay for quantifying type I collagen degradation products in urine evaluated Clin Chem 1994, 40:2022-2025. 7955372
4. Christgau S Garnero P Fledelius C Moniz C Ensig M Gineyts E Rosenquist C Qvist P Collagen type II C-telopeptide fragments as an index of cartilage degradation Bone 2001, 29:209-215. 10.1016/ S8756-3282(01)00504-X 11557363
5. Schaller S Henriksen K Hoegh-Andersen P Sondergaard BC Sumer EU Tanko LB Qvist P Karsdal MA In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: How biomarkers can assist? Assay Drug Dev Technol 2005, 3:553-580. 10.1089/adt.2005.3.553 16305312
6. Garnero P Christgau S Delmas PD The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone Bone 2001, 28:461-464. 10.1016/S8756-3282(01)00431-8 11344044
7. Christgau S Tanko LB Cloos PA Mouritzen U Christiansen C Delaisse JM Hoegh-Andersen P Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM) Menopause 2004, 11:508-518. 10.1097/01.WCB.0000121484.18437.98 15356403
8. Mouritzen U Christgau S Lehmann HJ Tanko LB Christiansen C Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: Influence of age, sex, menopause, hormone replacement therapy, and body mass index Ann Rheum Dis 2003, 62:332-336. 1754496 12634232 10.1136/ard.62.4.332
9. Schreiweis MA Butler JP Kulkarni NH Knierman MD Higgs RE Halladay DL Onyia JE Hale JE A proteomic analysis of adult rat bone reveals the presence of cartilage/chondrocyte markers J Cell Biochem 2007, 101:466-476. 10.1002/jcb.21196 17205546
10. Leeming DJ Koizumi M Byrjalsen I Li B Qvist P Tanko LB The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients Cancer Epidemiol Biomarkers Prev 2006, 15:32-38. 10.1158/1055-9965.EPI-05-0492 16434583
11. Soloway MS Hardeman SW Hickey D Raymond J Todd B Soloway S Moinuddin M Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan Cancer 1988, 61:195-202. 10.1002/ 1097-0142(19880101)61:1<195::AID-CNCR2820610133>3.0.CO;2-Y 3334948
12. Cloos PA Lyubimova N Solberg H Qvist P Christiansen C Byrjalsen I Christgau S An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone Clin Lab 2004, 50:279-289. 15209436
13. Karsdal MA Hjorth P Henriksen K Kirkegaard T Nielsen KL Lou H Delaisse JM Foged NT Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression J Biol Chem 2003, 278:44975-44987. 10.1074/jbc.M303905200 12933809
14. Karsdal MA Henriksen K Sorensen MG Gram J Schaller S Dziegiel MH Heegaard AM Christophersen P Martin TJ Christiansen C Bollerslev J Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption Am J Pathol 2005, 166:467-476. 1602325 15681830
15. Jung K Lein M Stephan C Von Hosslin K Semjonow A Sinha P Loening SA Schnorr D Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: Diagnostic and prognostic implications Int J Cancer 2004, 111:783-791. 10.1002/ ijc.20314 15252851
16. Brown JE Cook RJ Major P Lipton A Saad F Smith M Lee KA Zheng M Hei YJ Coleman RE Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors J Natl Cancer Inst 2005, 97:59-69. 15632381
17. Brown JM Vessella RL Kostenuik PJ Dunstan CR Lange PH Corey E Serum osteoprotegerin levels are increased in patients with advanced prostate cancer Clin Cancer Res 2001, 7:2977-2983. 11595685
18. Hegele A Wahl HG Varga Z Sevinc S Koliva L Schrader AJ Hofmann R Olbert P Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer BJU Int 2007, 99:330-334. 10.1111/ j.1464-410X.2006.06604.x 17092281
19. Demers LM Costa L Lipton A Biochemical markers and skeletal metastases Cancer 2000, 88:2919-2926. 10.1002/1097-0142(20000615)88:12+ <2919::AID-CNCR7>3.0.CO;2-Z 10898335
20. Berruti A Dogliotti L Gorzegno G Torta M Tampellini M Tucci M Cerutti S Frezet MM Stivanello M Sacchetto G Angeli A Differential patterns of bone turnover in relation to bone pain and disease extent in bone in cancer patients with skeletal metastases Clin Chem 1999, 45:1240-1247. 10430790
21. Ali SM Demers LM Leitzel K Harvey HA Clemens D Mallinak N Engle L Chinchilli V Costa L Brady C Seaman J Lipton A Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis Ann Oncol 2004, 15:455-459. 10.1093/annonc/mdh089 14998848
22. Troen BR The role of cathepsin K in normal bone resorption Drug News Perspect 2004, 17:19-28. 10.1358/dnp.2004.17.1.829022 14993931